Scripps Center for Metabolomics, Scripps Research, La Jolla, CA 92037, USA.
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Sci Signal. 2022 Nov 29;15(762):eabo7940. doi: 10.1126/scisignal.abo7940.
The lipid kinase VPS34 orchestrates autophagy, endocytosis, and metabolism and is implicated in cancer and metabolic disease. The proximal tubule in the kidney is a key metabolic organ that controls reabsorption of nutrients such as fatty acids, amino acids, sugars, and proteins. Here, by combining metabolomics, proteomics, and phosphoproteomics analyses with functional and superresolution imaging assays of mice with an inducible deficiency in proximal tubular cells, we revealed that VPS34 controlled the metabolome of the proximal tubule. In addition to inhibiting pinocytosis and autophagy, VPS34 depletion induced membrane exocytosis and reduced the abundance of the retromer complex necessary for proper membrane recycling and lipid retention, leading to a loss of fuel and biomass. Integration of omics data into a kidney cell metabolomic model demonstrated that VPS34 deficiency increased β-oxidation, reduced gluconeogenesis, and enhanced the use of glutamine for energy consumption. Furthermore, the omics datasets revealed that VPS34 depletion triggered an antiviral response that included a decrease in the abundance of apically localized virus receptors such as ACE2. VPS34 inhibition abrogated SARS-CoV-2 infection in human kidney organoids and cultured proximal tubule cells in a glutamine-dependent manner. Thus, our results demonstrate that VPS34 adjusts endocytosis, nutrient transport, autophagy, and antiviral responses in proximal tubule cells in the kidney.
脂质激酶 VPS34 协调自噬、内吞作用和代谢,与癌症和代谢疾病有关。肾脏中的近端小管是一个关键的代谢器官,控制着脂肪酸、氨基酸、糖和蛋白质等营养物质的重吸收。在这里,我们通过将代谢组学、蛋白质组学和磷酸化蛋白质组学分析与具有诱导性近端肾小管细胞缺陷的小鼠的功能和超分辨率成像测定相结合,揭示了 VPS34 控制近端小管的代谢组。除了抑制胞饮作用和自噬作用外,VPS34 耗竭还诱导了膜胞吐作用,并减少了膜回收和脂质保留所必需的逆行复体复合物的丰度,导致燃料和生物量的丧失。将组学数据整合到肾脏细胞代谢组模型中表明,VPS34 缺乏增加了 β-氧化,减少了糖异生,并增强了谷氨酰胺用于能量消耗。此外,组学数据集表明,VPS34 耗竭触发了抗病毒反应,包括减少顶端定位的病毒受体(如 ACE2)的丰度。VPS34 抑制以依赖于谷氨酰胺的方式消除了 SARS-CoV-2 在人类肾类器官和培养的近端肾小管细胞中的感染。因此,我们的结果表明,VPS34 调节了肾脏近端肾小管细胞中的内吞作用、营养物质运输、自噬和抗病毒反应。